Evidence map›Paper›PMID 21871134›Full record

ArticleJournal of neuroinflammation2011

Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-α/TACE in focal cerebral ischemia in mice.

Yi Yang, Fakhreya Y Jalal, Jeffrey F Thompson, Espen J Walker, Eduardo Candelario-Jalil, Lu Li, Ross R Reichard, Chi Ben, Qing-Xiang Sang, Lee Anna Cunningham and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Exosomes in pathogenesis, diagnosis, and therapy of ischemic stroke.Frontiers in bioengineering and biotechnology · 2022
    Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Neuroinflammation: friend and foe for ischemic stroke.Journal of neuroinflammation · 2019
    Review
  20. TIMP-3 as a therapeutic target for cancer.Therapeutic advances in medical oncology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yi YangDepartment of Neurology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Fakhreya Y Jalal
Jeffrey F Thompson
Espen J Walker
Eduardo Candelario-Jalil
Lu Li
Ross R Reichard
Chi Ben
Qing-Xiang Sang
Lee Anna Cunningham
Gary A Rosenberg
University of New Mexico · USFlorida State University · USUniversity of California, San Francisco · US

Funding

White matter hypoxia in a novel model of MMP-mediated inflammation in SHR/SPR01NS045847 · NINDS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI ROSENBERG, GARY ALLEN · 2003 to 2017
$3.7M
NINDS NIH HHS 2 R01 NS045847-05A2NINDS NIH HHS 5R01NS04547
6 · The paper itself

Abstract

background and purposeOligodendrocyte (OL) death is important in focal cerebral ischemia. TIMP-3 promotes apoptosis in ischemic neurons by inhibiting proteolysis of TNF-α superfamily of death receptors. Since OLs undergo apoptosis during ischemia, we hypothesized that TIMP-3 contributes to OL death.

methodsMiddle cerebral artery occlusion (MCAO) was induced in Timp-3 knockout (KO) and wild type (WT) mice with 24 or 72 h of reperfusion. Cell death in white matter was investigated by stereology and TUNEL. Mature or immature OLs were identified using antibodies against glutathione S-transferase-π (GST-π) and galactocerebroside (GalC), respectively. Expression and level of proteins were examined using immunohistochemistry and immunoblotting. Protein activities were determined using a FRET peptide.

resultsLoss of OL-like cells was detected at 72 h only in WT ischemic white matter where TUNEL showed greater cell death. TIMP-3 expression was increased in WT reactive astrocytes. GST-π was reduced in ischemic white matter of WT mice compared with WT shams with no difference between KO and WT at 72 h. GalC level was significantly increased in both KO and WT ischemic white matter at 72 h. However, the increase in GalC in KO mice was significantly higher than WT; most TUNEL-positive cells in ischemic white matter expressed GalC, suggesting TIMP-3 deficiency protects the immature OLs from apoptosis. There were significantly higher levels of cleaved caspase-3 at 72 h in WT white matter than in KO. Greater expression of MMP-3 and -9 was seen in reactive astrocytes and/or microglia/macrophages in WT at 72 h. We found more microglia/macrophages in WT than in KO, which were the predominant source of increased TNF-α detected in the ischemic white matter. TACE activity was significantly increased in ischemic WT white matter, which was expressed in active microglia/macrophages and OLs.

conclusionsOur results suggested that focal ischemia leads to proliferation of immature OLs in white matter and that TIMP-3 contributes to a caspase-3-dependent immature OL death via TNF-α-mediated neuroinflammation. Future studies will be needed to delineate the role of MMP-3 and MMP-9 that were increased in the Timp-3 wild type.

Indexed as

ADAM17 ProteinADAM ProteinsAnimalsBrainBrain IschemiaCaspase 3Cell DeathFluorescence Resonance Energy TransferInfarction, Middle Cerebral ArteryIn Situ Nick-End LabelingMaleMatrix Metalloproteinase 3Matrix Metalloproteinase 9MiceMice, KnockoutOligodendrogliaADAM17 ProteinAdam17 protein, mouseADAM ProteinsCaspase 3Matrix Metalloproteinase 3Matrix Metalloproteinase 9Tissue Inhibitor of Metalloproteinase-3Tumor Necrosis Factor-alpha

Identifiers

PMID21871134
PMCPMC3180275
OpenAlexW2085434027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.